Sean J Pittock Selected Research

Nervous System Diseases (Neurological Disorders)

11/2020	GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin-Associated Ataxia and Neuropathy.
1/2020	High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display.
10/2018	Paraneoplastic neuronal intermediate filament autoimmunity.
10/2018	GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
1/2018	LGI1 and CASPR2 neurological autoimmunity in children.
2/2017	Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
1/2017	Autoimmune Neurology of the Central Nervous System.
8/2016	Autoantibody-Associated Central Nervous System Neurologic Disorders.
1/2016	Current and future immunotherapy targets in autoimmune neurology.
11/2014	The neurologic significance of celiac disease biomarkers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sean J Pittock Research Topics

Disease

59	Neuromyelitis Optica (Devic's Disease) 03/2022 - 12/2004
45	Neoplasms (Cancer) 03/2022 - 05/2003
32	Multiple Sclerosis 02/2022 - 12/2004
19	Optic Neuritis (Retrobulbar Neuritis) 02/2022 - 07/2005
18	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 07/2007
16	Nervous System Diseases (Neurological Disorders) 11/2020 - 05/2003
15	Seizures (Absence Seizure) 01/2021 - 01/2003
13	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 12/2014
13	Myelitis 01/2021 - 01/2006
12	Glioma (Gliomas) 01/2022 - 05/2012
12	Transverse Myelitis (Necrotizing Myelitis) 01/2021 - 01/2006
12	Neurologic Manifestations (Neurological Manifestations) 10/2020 - 07/2005
11	Ataxia (Dyssynergia) 12/2021 - 09/2008
10	Spinal Cord Diseases 10/2021 - 03/2002
10	Inflammation (Inflammations) 01/2021 - 10/2008
10	Brain Diseases (Brain Disorder) 01/2021 - 10/2008
9	Epilepsy (Aura) 02/2021 - 05/2012
7	Autoimmune Diseases of the Nervous System 01/2022 - 11/2011
6	Myasthenia Gravis 01/2022 - 01/2009
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2020 - 04/2008
6	Breast Neoplasms (Breast Cancer) 11/2019 - 07/2005
6	Cerebellar Ataxia (Dysmetria) 10/2018 - 10/2009
6	Dementia (Dementias) 01/2017 - 10/2008
5	Leukocytosis (Pleocytosis) 01/2022 - 10/2010
5	Pain (Aches) 01/2020 - 09/2012
5	Stiff-Person Syndrome (Stiff Man Syndrome) 10/2018 - 12/2009
4	Neuralgia (Stump Neuralgia) 12/2021 - 01/2018
4	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2021 - 07/2005
4	Central Nervous System Diseases (CNS Diseases) 02/2021 - 02/2008
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2012
4	Thymoma (Thymic Carcinoma) 12/2020 - 07/2014
4	Edema (Dropsy) 01/2020 - 10/2008
4	Polyneuropathies (Polyneuropathy) 01/2020 - 10/2002
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 09/2006
4	Myoclonus (Nocturnal Myoclonus) 01/2020 - 09/2007
4	Cognitive Dysfunction 10/2018 - 04/2010
4	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 12/2017 - 05/2003
4	Teratoma (Teratoid Tumor) 01/2017 - 04/2010
3	Muscular Diseases (Myopathy) 01/2022 - 08/2014
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 12/2021 - 01/2016
3	Polyradiculoneuropathy (Polyradiculoneuritis) 12/2021 - 01/2018
3	Respiratory Tract Infections (Respiratory Tract Infection) 05/2021 - 01/2003
3	Meningoencephalitis 02/2021 - 11/2016
3	Optic Nerve Diseases (Optic Neuropathy) 01/2020 - 01/2012
3	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2019 - 08/2009
3	Optic Atrophy 01/2018 - 10/2011
3	Small Cell Carcinoma 12/2017 - 03/2013
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2015 - 06/2009
2	Memory Disorders (Memory Loss) 01/2022 - 01/2019
2	Headache (Headaches) 05/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2021 - 07/2014
2	Infarction (Infarctions) 01/2021 - 01/2018
2	Stroke (Strokes) 01/2021 - 07/2003

Drug/Important Bio-Agent (IBA)

108	Immunoglobulin G (IgG)IBA 03/2022 - 05/2003
77	AutoantibodiesIBA 01/2022 - 05/2003
44	AntibodiesIBA 01/2022 - 11/2004
30	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
25	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
23	Myelin-Oligodendrocyte GlycoproteinIBA 02/2022 - 01/2018
15	Aquaporin 4IBA 10/2021 - 07/2006
14	Aquaporins (Water Channels)IBA 01/2022 - 08/2005
14	AntigensIBA 01/2020 - 11/2004
12	Leucine (L-Leucine)FDA Link 01/2022 - 05/2012
12	Complement System Proteins (Complement)IBA 01/2022 - 07/2007
12	Semaphorin-3AIBA 01/2022 - 07/2005
12	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 04/2010
10	Cholinergic ReceptorsIBA 01/2022 - 09/2007
10	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2020 - 09/2007
8	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2021 - 09/2006
8	N-Methylaspartate (NMDA)IBA 01/2021 - 11/2011
8	amphiphysinIBA 10/2020 - 07/2005
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2009
7	Immunoglobulins (Immunoglobulin)IBA 11/2020 - 02/2008
6	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 11/2012
6	eculizumab FDA Link 01/2022 - 06/2013
6	AutoantigensIBA 01/2022 - 07/2005
6	Calcium Channels (Calcium Channel)IBA 01/2020 - 10/2009
6	SteroidsIBA 09/2017 - 09/2010
5	Oligoclonal BandsIBA 01/2022 - 01/2015
5	Glial Fibrillary Acidic ProteinIBA 02/2021 - 11/2016
4	inebilizumabIBA 01/2022 - 10/2019
4	ANNA1 antibodyIBA 01/2022 - 02/2009
4	GadoliniumIBA 10/2021 - 07/2017
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2007
3	Immunoglobulin M (IgM)IBA 12/2021 - 10/2008
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2016
3	EpitopesIBA 01/2020 - 01/2011
3	Peptides (Polypeptides)IBA 01/2020 - 08/2014
3	Glutamic Acid (Glutamate)FDA Link 01/2020 - 10/2008
3	Glycine Receptors (Glycine Receptor)IBA 01/2020 - 01/2013
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 05/2012
3	Rituximab (Mabthera)FDA Link 03/2018 - 09/2015
3	Potassium Channels (Potassium Channel)IBA 01/2017 - 09/2012
3	Immunoglobulin A (IgA)IBA 11/2014 - 01/2011
3	CationsIBA 05/2011 - 10/2009
2	Retinaldehyde (Retinal)IBA 02/2022 - 01/2019
2	Antinuclear AntibodiesIBA 01/2021 - 01/2008

Therapy/Procedure

39	Immunotherapy 01/2022 - 09/2006
22	Therapeutics 01/2022 - 05/2003
3	Plasmapheresis 01/2021 - 08/2009